Regenxbio Inc (NAS:RGNX)
$ 14.29 -0.06 (-0.42%) Market Cap: 703.87 Mil Enterprise Value: 453.30 Mil PE Ratio: 0 PB Ratio: 1.79 GF Score: 59/100

Regenxbio Inc Analyst and Investor Event Transcript

Feb 21, 2019 / 02:00PM GMT
Release Date Price: $45.68 (-1.19%)
Kenneth T. Mills
REGENXBIO Inc. - CEO, President & Director

Hey, good morning, everyone. I think we're going to get started. It seems like everyone who's going to arrive, has arrived, and settled in. Hopefully, everyone has gotten some breakfast, and is ready for the morning to get started.

So I see a lot of familiar face in the audience but also some new faces. So I'm Ken Mills, President and CEO of REGENXBIO, and we're happy today to invite you to our RGX-314 Analyst and Investor Day. This is also going to be webcast, so I'll be deliberately speaking into the microphone so that outside of the people that are here in New York, others who may be listening in can also hear what we're going to be getting into.

Definitely got a full agenda today, so I want to get right to it, but before I do, certainly, want to reflect on our risk factors and forward-looking statements. We will be making some forward-looking statements today. And if you have any questions about them, you can direct them to our General Counsel in Rockville at any time, they're always available.

Before I get

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot